Sumatriptan succinate

Overview

Sumatriptan succinate (GR 43175) is an orally active 5-HT1 receptor agonist with IC 50 s of 7.3 nm, 9.3nm and 17.8 nm for 5-HT 1D , 5-HT 1B and 5-HT 1F receptors, respectively. Sumatriptan succinate can be used for migraine headache research.

Application

Products | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Depression | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Neurodegenerative Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > 5-HT Receptor

Product Information

• Catalog No.: HY-B0121
• CAS No.: 103628-48-4
• Molecular Formula: C18H27N3O6S
• Molecular Weight: 413.49
• Purity: 99.89%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (6.05 mM); Clear solution
• Availability: In-stock

Source

Original product source